The cash flow of EXELON CORPORATION over the past 10 years
Chart EXELON CORPORATION: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, EXELON CORPORATION's operating cash flow was $6.25B and its capital expenditures $8.53B, leaving free cash flow of -$2.27B. Free cash flow was above zero in 1 of the 10 years shown. It ranged from -$4.97B in fiscal 2021 to $1.05B in fiscal 2018. Capital expenditures were highest in fiscal 2016, at $8.55B.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $6.25B | $8.53B | -$2.27B |
| 2024ended Dec 31, 2024 | $5.57B | $7.1B | -$1.53B |
| 2023ended Dec 31, 2023 | $4.7B | $7.41B | -$2.71B |
| 2022ended Dec 31, 2022 | $4.87B | $7.15B | -$2.28B |
| 2021ended Dec 31, 2021 | $3.01B | $7.98B | -$4.97B |
| 2020ended Dec 31, 2020 | $4.24B | $8.05B | -$3.81B |
| 2019ended Dec 31, 2019 | $6.66B | $7.25B | -$589M |
| 2018ended Dec 31, 2018 | $8.64B | $7.59B | $1.05B |
| 2017ended Dec 31, 2017 | $7.48B | $7.58B | -$104M |
| 2016ended Dec 31, 2016 | $8.46B | $8.55B | -$92M |
Fiscal years as EXELON CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on EXELON CORPORATION
- The revenue of EXELON CORPORATION
- The profitability of EXELON CORPORATION
- The debt of EXELON CORPORATION
- The dividends of EXELON CORPORATION
- All of EXELON CORPORATION's financials, charted
Companies of a similar size
- MNSTMonster Beverage Corp
- MSCIMSCI INC.
- AMPAMERIPRISE FINANCIAL, INC.
- IDXXIDEXX LABORATORIES INC /DE
- TEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED
Not investment advice. This page shows what EXELON CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.